Analysing Divi's Laboratories with Dr Tanmay Motiwala
Created on 01 Mar 2023
Wraps up in 12 Min
Read by 174 people
Updated on 03 Mar 2023
Introducing Dr Tanmay Motiwala - a man with a passion for paediatric surgery and a keen eye for the world of investments. When it comes to the world of stocks, Dr Motiwala is no ordinary investor. He combines his medical knowledge and analytical skills to make informed decisions in the market, and one of his top picks is none other than Divi's Laboratories. So, join us as we dive into the world of Divi's Laboratories with Dr Tanmay Motiwala, with his unique approach and expertise.
The pharmaceutical industry involves sourcing raw materials to produce Key Starting Materials (KSM), which are processed to create Active Pharmaceutical Ingredients (APIs). APIs are used to create finished dosage forms like tablets, capsules, and injections that are packaged and distributed to healthcare providers and patients.
You are missing out on so much.
To continue reading, Subscribe.
You can have unlimited access to all the Elite Articles. Log in to check if your Finology account is ready for Elite.
By Subscribing to Finology One, you can unlock more superpowers -
- Up to 3 premium articles every week
- 15+ Stock recommendations with Recipe.
- 45+ premium courses with Quest.
- Valuation Calculators and more tools with Ticker.
You get all of these in one, with One.
How was this article?
Like, comment or share.
Share your thoughts
We showed you ours, now you show us yours (opinions 😉)
Why not start a conversation?
Looks like nobody has said anything yet. Would you take this as an opportunity to start a discussion or a chat fight may be.
More titbits on the go
Analysing REC Ltd. with Sonam Shrivastava
21 Feb 2023
Analysing CAMS with Kirti Pimpalgaonkar
20 Feb 2023
Divi's Labs Ltd: A bet on Make in India
10 Dec 2022
Top 5 Logistics Stocks in India
21 Jun 2022